Form 4 for PIII P3 Health Partners Inc.
Accepted 2023-08-08 00:00:00 ET · period of report 2023-08-04 · accession 0001104659-23-088999 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-08 | 2023-08-04 | PIII | Bacchus Amir | Chief Medical Off, Dir | A - Grant | $0.00 | +1.00M | 2.01M | +99% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-08-04 | A | A | 1,000,000 | $0.00 | 2,005,193 | D | — | — | (F1) Represents a grant of restricted stock units ("RSUs") granted pursuant to the P3 Health Partners Inc. 2021 Incentive Award Plan in full satisfaction of the "Second Bonus" set forth in the Transaction Bonus Agreement between Reporting Person, the Issuer and P3 Health Group Management, LLC, dated May 2022. Each RSU represents a right to receive one share of Class A common stock. The RSUs will be settled in Class A common stock on the earlier of (i) December 31, 2023 and (ii) the closing of the Company's first underwritten offering and sale of common stock. |